You no longer have to tell your patients to simply avoid reaction-causing foods! A revolution in food allergy treatment is here.
The AllergyEasy® program treats more than just environmental allergies. Our sublingual food serum is designed to help patients tolerate more of the foods they enjoy.
Are there side effects or risks?
Because the serum contains the same particles found in nature, there are minimal side effects. And since drops have a more favorable safety profile than shots,1 they can be taken safely at home.
How long until patients see results?
The majority of patients achieve relief from food allergy symptoms in three to six months and can then continue on maintenance serum. Some patients start to feel better in just the first few weeks of treatment. Each patient is unique, and results may vary.
How did this treatment come about?
Sublingual immunotherapy (SLIT) has been used successfully worldwide since the mid-1980s to treat environmental allergies. Recent studies, including high-profile clinical trials at Duke University, have proven sublingual immunotherapy to be a safe and highly effective treatment program for food allergies as well.2
From AllergyEasy Patients:
“The allergy serum changed my daughter’s life. I now have a happy 4-year-old who can eat any wheat product, cheese, ice cream, pizza….all of those normal kid things.”
“I had allergies to onion, garlic and spices. After about a month on the drops, I began seeing a decrease in the severe headaches and gastrointestinal upset. For the first time in 20 years, I don’t have to actively avoid spicy foods.”
–Brent Silver, M.D
1Ciprandi G, Marseglia GL. “Safety of Sublingual Immunotherapy.” Journal of Biological Regulators and Homeostatic Agents 2011 Jan-Mar
2Kim EH, Bird JA, Kulius M, Laubach S, Pons L, Shreffler W, Steele P, Kamilaris J, Vickery B, Burks AW. “Sublingual immunotherapy for peanut allergy: clinical and immunologic evidence of desensitization.” Journal of Allergy & Clinical Immunology Mar 2011
3Rienzo VD, Minelli M, Musarra A, Sambugaro R, Pecora S, Canonica WG. “Post-marketing survey on the safety of sublingual immunotherapy in children below the age of 5 years.” Clinical and Experimental Allergy 2005, 35:560-4